News Feature Channel: Transplantation

Scientists Identify Potential New Genetic Target for Sickle Cell Disease Treatment

Johns Hopkins Medicine — Mon, 24 Mar 2025 18:05:38 EST

Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have identified a potential new gene target that could be edited to treat sickle cell disease, an inherited blood disorder marked by sickle-shaped red blood cells that cause intense pain and shorten lifespans.

American Society of Nephrology Calls on Congress to Authorize Legislation and Increase Funding for Kidney Diseases

American Society of Nephrology (ASN) — Wed, 19 Mar 2025 08:30:00 EST

Today, leaders from the American Society of Nephrology (ASN) will meet with their congressional delegations and call for their support of $67 million in funding for the Health Resources and Services Administration (HRSA) Organ Transplantation Program in FY 26.

Northwestern Medicine Launches Clinical Program to Make Liver Transplants More Accessible for Patients with Stage 4 Colorectal Cancer

Northwestern Medicine — Tue, 18 Mar 2025 11:00:00 EST

Northwestern Medicine launches clinical program to make liver transplants more accessible for patients with stage 4 colorectal cancer

From Part-Time Job to Long-Term Career: College Students Explore the Medical Field Through Work-Study Jobs at CHLA

Children's Hospital Los Angeles — Fri, 14 Mar 2025 20:25:07 EST

Children's Hospital Los Angeles developed work-study jobs for college students interested in medical careers

American Society of Nephrology Commends Senators Boozman and Lujan for Championing the Honor Our Living Donors (HOLD) Act

American Society of Nephrology (ASN) — Wed, 12 Mar 2025 10:35:12 EST

The American Society of Nephrology (ASN) commends Senators John Boozman (R-AR) and Ben Ray Lujan (D-NM) for introducing legislation to better support living donors, the Honor Our Living Donors (HOLD) Act.

Children's Hospital of Philadelphia Preclinical Study Demonstrates Improved Gene Therapy Approach to Treating Metachromatic Leukodystrophy

Children's Hospital of Philadelphia — Tue, 11 Mar 2025 19:20:06 EST

In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with potentially increased effectiveness and safety for the treatment for metachromatic leukodystrophy (MLD), a rare disease in young children characterized by the deficient activity of a critical enzyme.

Experts Bust 5 Myths About Living Kidney Donation

Mayo Clinic — Mon, 10 Mar 2025 10:50:01 EST

More than 90,000 people are on the waiting list for a kidney in the U.S. Unfortunately, less than a third of those waiting for a kidney transplant can expect to get one this year. This comes as rates of chronic kidney disease, which can lead to kidney failure, continue to climb across the globe. But there is a way to help.

Vanderbilt Lung Transplant Establishes New Record

Vanderbilt University Medical Center — Fri, 07 Mar 2025 19:50:41 EST

Surgeons and teams with Vanderbilt Lung Transplant performed 99 lung transplants in 2024, the most ever in one year. Two of the procedures involved combined organ transplants. For the second calendar year in a row, Vanderbilt Lung Transplant has the busiest program in the Southeast and leads the nation in innovation in organ preservation and regeneration.

Neurosurgeon Raises NIH Funding Concerns in Key Letter

UC San Diego Health — Wed, 05 Mar 2025 19:10:57 EST

Neurosurgery Urges Collaboration on NIH Indirect Cost Policy

Wed, 05 Mar 2025 18:40:18 EST

The AANS, CNS, and over 40 other leading medical organizations sent a joint letter to the National Institutes of Health (NIH), expressing concerns over the agency's new policy imposing a 15% cap on indirect cost rates for all NIH grants.

VUMC Part of New Study Validating Curative Therapy for Sickle Cell Disease

Vanderbilt University Medical Center — Tue, 04 Mar 2025 10:50:20 EST

A modified bone marrow transplant procedure for sickle cell disease (SCD) co-developed at Vanderbilt University Medical Center, Johns Hopkins University School of Medicine, and the University of California, San Francisco, can cure the disease, a new study has found.

Cedars-Sinai Establece un Nuevo Record en Trasplante de Organos

Cedars-Sinai — Fri, 28 Feb 2025 19:05:31 EST

Cedars-Sinai Comprehensive Transplant Center y el Smidt Heart Institute establecieron un nuevo record en 2024 al completar 682 trasplantes de organos solidos, la mayor cantidad que el centro medico ha realizado en un ano, ya que los resultados de supervivencia de los pacientes continuaron alcanzando o superando la media nacional.

Cedars-Sinai Sets New Record in Organ Transplantation

Cedars-Sinai — Fri, 28 Feb 2025 18:45:11 EST

The Cedars-Sinai Comprehensive Transplant Center and the Smidt Heart Institute set a new record in 2024 by completing 682 solid organ transplants--the most the medical center has performed in a year--as patient survival outcomes continued to meet or exceed the national average.

Procedimiento doble combina trasplante de higado y cirugia bariatrica

Mayo Clinic — Thu, 27 Feb 2025 11:10:02 EST

Cirujanos de Mayo Clinic descubrieron que un enfoque innovador puede ayudar a los pacientes con obesidad a recibir atencion vital. La obesidad puede ser una barrera para el transplante de higado. La Dra. Julie Heimbach, directora del Centro de Trasplantes de Mayo Clinic en Rochester, Minnesota, afirma que la combinacion de la cirugia de manga gastrica, un tipo de cirugia bariatrica, con el trasplante de higado, es eficaz para hacer frente a ambos problemas de salud.

Procedimento duplo combina transplante de figado e cirurgia bariatrica

Mayo Clinic — Thu, 27 Feb 2025 10:10:34 EST

Cirurgioes da Mayo Clinic descobriram que uma abordagem inovadora pode ajudar pacientes com obesidade a receber cuidados vitais. A obesidade pode ser uma barreira para o transplante de figado. A Dra. Julie Heimbach, diretora do Centro de Transplantes da Mayo Clinic em Rochester, Minnesota, afirma que a combinacao da cirurgia de manga gastrica, um tipo de cirurgia bariatrica, com o transplante de figado, e eficaz para lidar com ambos os problemas de saude.

إجراء مزدوج يجمع بين زراعة الكبد وجراحة علاج السُمنة يوم الكبد العالمي هو 19 أبريل.

Mayo Clinic — Thu, 27 Feb 2025 00:10:31 EST

روتشستر، ولاية مينيسوتا -- اكتشف جراحو مايو كلينك أسلوبًا مبتكرًا يمكن أن يساعد المرضى المصابين بالسُمنة في الحصول على رعاية منقذة للحياة. قد تشكل السُمنة عائقًا أمام زراعة الكبد. تقول جولي هيمباخ، دكتورة في الطب، مديرة مركز مايو كلينك لزراعة الأعضاء في روتشستر، ولاية مينيسوتا، يُعد الجمع بين جراحة تكميم المعدة، وهي نوع من جراحات علاج السُمنة، وزراعة الكبد طريقة فعالة في التعامل مع كلتا المشكلتين الصحتين.

Nephrology Updates February 2025

Ann and Robert H. Lurie Children's Hospital of Chicago — Wed, 26 Feb 2025 16:15:04 EST

We performed 44 kidney transplants in 2024 (up from 26 in calendar year 2023), a record for Lurie Children's and the most kidney transplants of any pediatric transplant program in the Nation. In addition, we maintain exceptional volumes, with the strongest 1 year patient and graft survival in the nation for pediatric kidney transplant.

WDR36 Inhibits the Osteogenic Differentiation and Migration of Periodontal Ligament Stem Cells

World Journal of Stem Cells — Wed, 26 Feb 2025 12:00:41 EST

BACKGROUNDPeriodontitis is an inflammatory disease caused by the host's immune response and various interactions between pathogens, which lead to the loss of connective tissue and bone. In recent years, mesenchymal stem cell (SC) transpla

Effect of Tandem Autologous Stem Cell Transplantation on Survival in Pediatric Patients with High-Risk Solid Tumors in South China

World Journal of Stem Cells — Wed, 26 Feb 2025 12:00:05 EST

BACKGROUNDDespite advances in treatment, the prognosis for patients with high-risk pediatric solid tumors remains dismal. Tandem autologous stem cell transplantation (ASCT) offers promise for improving outcomes in these patients. This study

Novel Bone Marrow Transplant Can Cure Sickle Cell Disease

Johns Hopkins Medicine — Tue, 25 Feb 2025 09:45:34 EST

A bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative for adults with sickle cell disease, according to results of a trial completed at Johns Hopkins and about 20 additional cancer centers nationwide and in London.